Results 301 to 310 of about 88,387 (345)
Biological Activity of Monoterpene-Based Scaffolds: A Natural Toolbox for Drug Discovery. [PDF]
Mołdoch J+3 more
europepmc +1 more source
Anticonvulsant Effects of Synthetic <i>N</i>-(3-Methoxybenzyl)oleamide and <i>N</i>-(3-Methoxybenzyl)linoleamide Macamides: An In Silico and In Vivo Study. [PDF]
Vera-López KJ+7 more
europepmc +1 more source
Anticonvulsant, Anticholinesterase and Cytoprotective Effects of the Aqueous Extract of Lippia sidoides Cham. [PDF]
Camilo CJ+10 more
europepmc +1 more source
Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model. [PDF]
Smith T+7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Statins – Are they anticonvulsant?
Pharmacological Reports, 2014Statins are the most popular and effective lipid-lowering medications beneficial in hypercholesterolemias and prevention of cardiovascular diseases. Growing evidence supports theory that statins exhibit neuroprotective action in acute stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis or epilepsy.
Monika Banach+2 more
openaire +4 more sources
ARE ANTICONVULSANTS ONCOGENIC?
The Lancet, 1974Abstract The duration of treatment with anti-convulsants—i.e., survival-time checked against national death files—and occurrence of neoplasms, ascertained by means of a cancer registry for 1943-67, were determined in 9136 cases of epilepsy admitted to a hospital from 1933 to 1962.
ClausM. Plum+2 more
openaire +3 more sources
Current Pain and Headache Reports, 2004
Migraine is a common, disabling disorder that often requires preventive treatment. The decision to treat migraine preventively generally is based on disability, problems with acute medicines, patient preference, risk of acute medication overuse, special circumstances, and concern that high migraine attack frequency may be a risk factor for chronic ...
HC Siow+2 more
openaire +3 more sources
Migraine is a common, disabling disorder that often requires preventive treatment. The decision to treat migraine preventively generally is based on disability, problems with acute medicines, patient preference, risk of acute medication overuse, special circumstances, and concern that high migraine attack frequency may be a risk factor for chronic ...
HC Siow+2 more
openaire +3 more sources
Intraction of the Anticonvulsant Ameltolide with standard Anticonvulsants
Epilepsia, 1992Summary: The newly characterized anticonvulsant ameltolide was studied in mice in combination with the standard antiepileptic drugs (AEDs), phenytoin (PHT), carbamazepine (CBZ), and valproate (VPA). In combination with either PHT or CBZ, ameltolide produced dose‐ additive effects in the maximal electroshock (MES) lest and in the horizontal screen (HS)
openaire +3 more sources